- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 487/08 - Bridged systems
Patent holdings for IPC class C07D 487/08
Total number of patents in this class: 1729
10-year publication summary
|
124
|
103
|
110
|
114
|
121
|
135
|
131
|
184
|
176
|
56
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
93 |
| Janssen Pharmaceutica N.V. | 3839 |
41 |
| Novartis AG | 11238 |
33 |
| Boehringer Ingelheim International GmbH | 4629 |
33 |
| Merck Sharp & Dohme LLC | 3689 |
32 |
| Gilead Sciences, Inc. | 1879 |
30 |
| F. Hoffmann-La Roche AG | 7958 |
24 |
| Genentech, Inc. | 3742 |
23 |
| Vertex Pharmaceuticals Incorporated | 1581 |
22 |
| Hoffmann-La Roche Inc. | 3060 |
20 |
| Pfizer Inc. | 3322 |
19 |
| Rigel Pharmaceuticals, Inc. | 613 |
19 |
| Astellas Pharma Inc. | 1145 |
16 |
| Incyte Corporation | 918 |
15 |
| Biosplice Therapeutics, Inc. | 166 |
15 |
| Astex Therapeutics Limited | 267 |
14 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
14 |
| Sanofi | 3836 |
13 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
12 |
| Clarity Pharmaceuticals Limited | 29 |
12 |
| Other owners | 1229 |